Page last updated: 2024-10-31

mirtazapine and Klebsiella Infections

mirtazapine has been researched along with Klebsiella Infections in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Klebsiella Infections: Infections with bacteria of the genus KLEBSIELLA.

Research Excerpts

ExcerptRelevanceReference
"We present a case of a patient who developed seizures shortly after initiating treatment with levofloxacin and to discuss the potential drug-drug interactions related to the inhibition of cytochrome P450 (CYP) 1A2 in this case, as well as in other cases, of levofloxacin-induced seizures."8.85Seizures associated with levofloxacin: case presentation and literature review. ( Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G, 2009)
"We present a case of a patient who developed seizures shortly after initiating treatment with levofloxacin and to discuss the potential drug-drug interactions related to the inhibition of cytochrome P450 (CYP) 1A2 in this case, as well as in other cases, of levofloxacin-induced seizures."4.85Seizures associated with levofloxacin: case presentation and literature review. ( Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellon, A1
Perez-Garcia, G1
Coverdale, JH1
Chacko, RC1

Reviews

1 review available for mirtazapine and Klebsiella Infections

ArticleYear
Seizures associated with levofloxacin: case presentation and literature review.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:10

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cytochrome

2009